Literature DB >> 16932733

Cognitive behavioral therapy for fibromyalgia.

Robert Bennett1, David Nelson.   

Abstract

Cognitive behavioral therapy (CBT) techniques offer short-term, goal-oriented psychotherapy. In this respect, it differs from classical psychoanalysis in emphasizing changes in thought patterns and behaviors rather than providing 'deep insight'. Importantly, the beneficial effects of CBT can be achieved in 10-20 sessions, compared with the many years required for classical psychoanalysis. Although CBT is often done on a one-to-one basis, it also lends itself to a group therapeutic setting. CBT was initially used in the treatment of mood disorders, but its use has subsequently been expanded to include various other medical conditions, including chronic pain states. Over the past 18 years, several chronic pain treatment programs have used CBT techniques in the management of fibromyalgia. In this review, the results from 13 programs using CBT, alone or in combination with other treatment modalities, are analyzed. In most studies, CBT provided worthwhile improvements in pain-related behavior, self-efficacy, coping strategies and overall physical function. Sustained improvements in pain were most evident when individualized CBT was used to treat patients with juvenile fibromyalgia. The current data indicate that CBT, as a single treatment modality, does not offer any distinct advantage over well-planned group programs of education or exercise, or both. Its role in the management of fibromyalgia patients needs further research.

Entities:  

Mesh:

Year:  2006        PMID: 16932733     DOI: 10.1038/ncprheum0245

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


  31 in total

1.  The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial.

Authors:  Ilknur Saral; Dilsad Sindel; Sina Esmaeilzadeh; Hanife Ozlem Sertel-Berk; Aydan Oral
Journal:  Rheumatol Int       Date:  2016-04-07       Impact factor: 2.631

2.  Exploratory Investigation of a Brief Cognitive Behavioral Intervention and Transcranial Direct Current Stimulation on Odor Sensitivity.

Authors:  David C Houghton; Thomas W Uhde; Jeffrey J Borckardt; Bernadette M Cortese
Journal:  Psychosom Med       Date:  2019-05       Impact factor: 4.312

3.  The Complex Relationship between Pain Intensity and Physical Functioning in Fibromyalgia: The Mediating Role of Depression.

Authors:  Jennifer L Steiner; Silvia M Bigatti; James E Slaven; Dennis C Ang
Journal:  J Appl Biobehav Res       Date:  2017-04-20

Review 4.  The role of antipsychotics in the management of fibromyalgia.

Authors:  Elena P Calandre; Fernando Rico-Villademoros
Journal:  CNS Drugs       Date:  2012-02-01       Impact factor: 5.749

5.  2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary.

Authors:  Mary-Ann Fitzcharles; Peter A Ste-Marie; Don L Goldenberg; John X Pereira; Susan Abbey; Manon Choinière; Gordon Ko; Dwight E Moulin; Pantelis Panopalis; Johanne Proulx; Yoram Shir
Journal:  Pain Res Manag       Date:  2013 May-Jun       Impact factor: 3.037

6.  [Effects of a cognitive-behavioral patient education on fibromyalgia: a controlled efficacy study].

Authors:  M Lange; B Krohn-Grimberghe; F Petermann
Journal:  Z Rheumatol       Date:  2011-06       Impact factor: 1.372

7.  [Psychotherapy in patients with fibromyalgia syndrome].

Authors:  K Thieme; W Häuser; A Batra; K Bernardy; E Felde; M Gesmann; A Illhardt; M Settan; R Wörz; V Köllner
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 8.  Systematic review of psychological treatment in fibromyalgia.

Authors:  María José Lami; María Pilar Martínez; Ana Isabel Sánchez
Journal:  Curr Pain Headache Rep       Date:  2013-07

Review 9.  Are psychological treatments effective for fibromyalgia pain?

Authors:  Kati Thieme; Richard H Gracely
Journal:  Curr Rheumatol Rep       Date:  2009-12       Impact factor: 4.592

Review 10.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.